Company profile GLYC

GlycoMimetics Inc
at glycomimetics, we are committed to helping to make a difference in the lives of people living with sickle cell, cancer, and other serious diseases. our mission is to continue to advance our research and clinical candidates, providing hope for patients as we strive for tomorrow’s breakthrough treatments. glycomimetics is a clinical-stage biotechnology company. we use novel ...and proprietary glycobiology technology to develop treatments for diseases, particularly where there is high unmet need. since the company’s inception in 2003, we have developed a robust, diversified product pipeline. we are a public company traded on the nasdaq under the symbol glyc. Show More
Quarter analysis & expected interest

There is not enough data for GlycoMimetics -drugs to provide analysis

Correlation between past revenue and GlycoMimetics -drugs search interest

There is not enough data for GlycoMimetics -drugs to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for GlycoMimetics -drugs to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for GlycoMimetics login to provide analysis

Correlation between past revenue and GlycoMimetics login search interest

There is not enough data for GlycoMimetics login to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for GlycoMimetics login to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for GlycoMimetics careers to provide analysis

Correlation between past revenue and GlycoMimetics careers search interest

There is not enough data for GlycoMimetics careers to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for GlycoMimetics careers to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for GlycoMimetics uproleselan to provide analysis

Correlation between past revenue and GlycoMimetics uproleselan search interest

There is not enough data for GlycoMimetics uproleselan to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for GlycoMimetics uproleselan to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for GlycoMimetics GMI-1687 to provide analysis

Correlation between past revenue and GlycoMimetics GMI-1687 search interest

There is not enough data for GlycoMimetics GMI-1687 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for GlycoMimetics GMI-1687 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for GlycoMimetics galectin-3 antagonists to provide analysis

Correlation between past revenue and GlycoMimetics galectin-3 antagonists search interest

There is not enough data for GlycoMimetics galectin-3 antagonists to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for GlycoMimetics galectin-3 antagonists to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for GlycoMimetics GMI-1359 to provide analysis

Correlation between past revenue and GlycoMimetics GMI-1359 search interest

There is not enough data for GlycoMimetics GMI-1359 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for GlycoMimetics GMI-1359 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for GlycoMimetics National Cancer Institute to provide analysis

Correlation between past revenue and GlycoMimetics National Cancer Institute search interest

There is not enough data for GlycoMimetics National Cancer Institute to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for GlycoMimetics National Cancer Institute to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for GlycoMimetics Apollomics to provide analysis

Correlation between past revenue and GlycoMimetics Apollomics search interest

There is not enough data for GlycoMimetics Apollomics to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for GlycoMimetics Apollomics to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for GlycoMimetics Rockville to provide analysis

Correlation between past revenue and GlycoMimetics Rockville search interest

There is not enough data for GlycoMimetics Rockville to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for GlycoMimetics Rockville to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for GLYC
Earnings date: 2024-02-29 After close
Company name: GlycoMimetics Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2025-10-14T15:41:05-04:00

SEC
SCHEDULE 13G/A Form - [Amend] Statement of Beneficial Ownership by Certain Investors - CRESCENT BIOPHARMA, INC. (0001253689) (Subject)

2025-10-09T16:15:11-04:00

SEC
SCHEDULE 13G Form - Statement of Beneficial Ownership by Certain Investors - CRESCENT BIOPHARMA, INC. (0001253689) (Subject)

2025-07-31T07:36:17-04:00

SEC
8-K Form - Current report, items 2.02, 5.02, and 9.01 - CRESCENT BIOPHARMA, INC. (0001253689) (Filer)

2025-07-31T07:25:56-04:00

SEC
10-Q Form - Quarterly report [Sections 13 or 15(d)] - CRESCENT BIOPHARMA, INC. (0001253689) (Filer)

2025-06-23T18:51:54-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - GLYCOMIMETICS INC (0001253689) (Issuer)

2025-06-23T18:48:57-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - GLYCOMIMETICS INC (0001253689) (Issuer)

2025-06-23T18:46:20-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - GLYCOMIMETICS INC (0001253689) (Issuer)

2025-06-23T18:43:51-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - GLYCOMIMETICS INC (0001253689) (Issuer)

2025-06-23T18:41:28-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - GLYCOMIMETICS INC (0001253689) (Issuer)

2025-06-23T18:32:36-04:00

SEC
SCHEDULE 13D Form - General Statement of Acquisition of Beneficial Ownership - GLYCOMIMETICS INC (0001253689) (Subject)

2025-06-23T18:29:48-04:00

SEC
3 Form - Initial statement of beneficial ownership of securities - GLYCOMIMETICS INC (0001253689) (Issuer)

2025-06-23T18:29:03-04:00

SEC
3 Form - Initial statement of beneficial ownership of securities - GLYCOMIMETICS INC (0001253689) (Issuer)

2025-06-23T18:28:16-04:00

SEC
3 Form - Initial statement of beneficial ownership of securities - GLYCOMIMETICS INC (0001253689) (Issuer)

2025-06-23T18:27:24-04:00

SEC
3 Form - Initial statement of beneficial ownership of securities - GLYCOMIMETICS INC (0001253689) (Issuer)

2025-06-23T18:26:43-04:00

SEC
3 Form - Initial statement of beneficial ownership of securities - GLYCOMIMETICS INC (0001253689) (Issuer)